Business Context and Reporting Period
This Form 8-K is a current report filed by WellPoint, Inc. (now Elevance Health, Inc.) on May 27, 2011, regarding events occurring on May 26, 2011. The filing addresses Item 5.02, concerning the departure of certain officers and the appointment of new officers.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figure disclosed is a grant date fair value of approximately $150,000 for restricted stock units awarded to a new appointee.
Material Changes
- Appointment of Chief Accounting Officer: John E. Gallina was appointed as Chief Accounting Officer, Senior Vice President, Controller, and Chief Risk Officer, effective May 26, 2011.
- Departure of Former Officer: Martin L. Miller was removed without cause from his positions as Senior Vice President, Chief Accounting Officer, Controller, and Chief Risk Officer effective immediately. The company stated his departure is not related to financial statements or accounting practices.
- Upcoming CFO Appointment: Jeffrey P. Fusile is scheduled to join as Senior Vice President and Chief Financial Officer for Strategic Business Units and Centers of Enterprise Excellence, replacing George L. Walker, who is retiring after 28 years.
Management Commentary and Risks
Management explicitly stated that Mr. Miller's departure was not related to the Company's financial statements or accounting practices. Mr. Gallina, who has been with the company since 1994, will receive a grant of restricted stock units valued at approximately $150,000 on June 1, 2011. No specific risks or contingencies beyond standard executive turnover were disclosed in this report.
Key Facts for Investor Verification
- Confirm the official reason for Martin L. Miller's removal, despite the company's statement that it is unrelated to accounting practices.
- Verify the transition timeline for Jeffrey P. Fusile's arrival as the new CFO for Strategic Business Units.
- Review subsequent filings to ensure no undisclosed accounting issues arise following the change in the Chief Accounting Officer.